Ferguson M R, Xu X J, Houston C W, Peterson J W, Coppenhaver D H, Popov V L, Chopra A K
Department of Microbiology and Immunology, The University of Texas Medical Branch, Galveston 77555-1070, USA.
Infect Immun. 1997 Oct;65(10):4299-308. doi: 10.1128/iai.65.10.4299-4308.1997.
A gene encoding the cytotoxic enterotoxin (Act) from Aeromonas hydrophila was hyperexpressed with the pET, pTRX, and pGEX vector systems. Maximum toxin yield was obtained with the pTRX vector. Approximately 40 to 60% of Act was in a soluble form with the pTRX and pET vector systems. The toxin protein was purified to homogeneity by a combination of ammonium sulfate precipitation and fast protein liquid chromatography-based column chromatographies, including hydrophobic, anion-exchange, sizing, and hydroxylapatite chromatographies. Purified mature toxin migrated as a 52-kDa polypeptide on a sodium dodecyl sulfate (SDS)polyacrylamide gel that reacted with Act-specific antibodies in immunoblots. The minimal amount of toxin needed to cause fluid secretion in rat ileal loops was 200 ng, and the 50% lethal dose for mice was 27.5 ng when injected intravenously. Binding of the toxin to erythrocytes was temperature dependent, with no binding occurring at 4 degrees C. However, at 37 degrees C the toxin bound to erythrocytes within 1 to 2 min. It was determined that the mechanism of action of the toxin involved the formation of pores in erythrocyte membranes, and the diameter of the pores was estimated to be 1.14 to 2.8 nm, as determined by the use of saccharides of different sizes and by electron microscopy. Calcium chloride prevented lysis of erythrocytes by the toxin; however, it did not affect the binding and pore-forming capabilities of the toxin. A dose-dependent reduction in hemoglobin release from erythrocytes was observed when Act was preincubated with cholesterol, but not with myristylated cholesterol. With 14C-labeled cholesterol and gel filtration, the binding of cholesterol to Act was demonstrated. None of the other phospholipids and glycolipids tested reduced the hemolytic activity of Act. The toxin also appeared to undergo aggregation when preincubated with cholesterol, as determined by SDS-polyacrylamide gel electorphoresis. As a result of this aggregation, Act's capacity to form pores in the erythrocyte membrane was inhibited.
编码嗜水气单胞菌细胞毒性肠毒素(Act)的基因通过pET、pTRX和pGEX载体系统进行了高效表达。使用pTRX载体时毒素产量最高。使用pTRX和pET载体系统时,约40%至60%的Act呈可溶形式。通过硫酸铵沉淀和基于快速蛋白质液相色谱的柱色谱法(包括疏水色谱、阴离子交换色谱、尺寸排阻色谱和羟基磷灰石色谱)相结合,将毒素蛋白纯化至同质。纯化的成熟毒素在十二烷基硫酸钠(SDS)聚丙烯酰胺凝胶上迁移为52 kDa的多肽,在免疫印迹中与Act特异性抗体发生反应。在大鼠回肠袢中引起液体分泌所需的最小毒素量为200 ng,静脉注射时对小鼠的半数致死剂量为27.5 ng。毒素与红细胞的结合具有温度依赖性,在4℃时不发生结合。然而,在37℃时,毒素在1至2分钟内与红细胞结合。已确定毒素的作用机制涉及在红细胞膜上形成孔,通过使用不同大小的糖类和电子显微镜确定,孔的直径估计为1.14至2.8 nm。氯化钙可防止毒素引起红细胞裂解;然而,它不影响毒素的结合和形成孔的能力。当Act与胆固醇预孵育时,观察到红细胞血红蛋白释放呈剂量依赖性降低,但与肉豆蔻酰化胆固醇预孵育时未观察到这种情况。通过14C标记的胆固醇和凝胶过滤,证明了胆固醇与Act的结合。所测试的其他磷脂和糖脂均未降低Act的溶血活性。通过SDS-聚丙烯酰胺凝胶电泳确定,毒素在与胆固醇预孵育时似乎也会发生聚集。由于这种聚集,Act在红细胞膜上形成孔道的能力受到抑制。